Nuzenio

Cancer Research Kalkine

Cancer Research Kalkine news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 2 publisher sources 100/100 entity strength

Latest news

What Does Merck’s (NYSE:MRK) Latest Trial Setback Mean? - Kalkine MediaKalkine Media · Sun, 09 Aug 2026 15:11:00 GMTSona Nanotech to Raise $2.4 Million via Private Placement to Advance Targeted Hyperthermia Therapy Cancer Research - Kalkine MediaKalkine Media · Wed, 05 Aug 2026 17:15:25 GMTWhy CelLBxHealth (LSE:CLBX) Is Drawing Fresh Attention in Cancer Research - Kalkine MediaKalkine Media · Tue, 04 Aug 2026 05:43:00 GMTAmplia Therapeutics' Narmafotinib Pancreatic Cancer Study Published on bioRxiv - KalkineKalkine · Fri, 31 Jul 2026 07:00:00 GMTAmplia Therapeutics Publishes Preclinical Pancreatic Cancer Study on Narmafotinib via bioRxiv - Kalkine MediaKalkine Media · Fri, 31 Jul 2026 07:00:00 GMTVerastem Oncology (NASDAQ:VSTM) Draws Fresh Market Focus - Kalkine MediaKalkine Media · Wed, 29 Jul 2026 21:52:00 GMTBionomics Ltd - KalkineKalkine · Wed, 29 Jul 2026 06:24:13 GMT

Timeline

Sun, 09 Aug 2026 15:11:00 GMTWhat Does Merck’s (NYSE:MRK) Latest Trial Setback Mean? - Kalkine Media
Wed, 05 Aug 2026 17:15:25 GMTSona Nanotech to Raise $2.4 Million via Private Placement to Advance Targeted Hyperthermia Therapy Cancer Research - Kalkine Media
Tue, 04 Aug 2026 05:43:00 GMTWhy CelLBxHealth (LSE:CLBX) Is Drawing Fresh Attention in Cancer Research - Kalkine Media
Fri, 31 Jul 2026 07:00:00 GMTAmplia Therapeutics' Narmafotinib Pancreatic Cancer Study Published on bioRxiv - Kalkine
Fri, 31 Jul 2026 07:00:00 GMTAmplia Therapeutics Publishes Preclinical Pancreatic Cancer Study on Narmafotinib via bioRxiv - Kalkine Media
Wed, 29 Jul 2026 21:52:00 GMTVerastem Oncology (NASDAQ:VSTM) Draws Fresh Market Focus - Kalkine Media

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Cancer Research Kalkine.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.